39 related articles for article (PubMed ID: 16398612)
1. Isolation of scFvs to in vitro produced extracellular domains of EGFR family members.
Horak E; Heitner T; Robinson MK; Simmons HH; Garrison J; Russeva M; Furmanova P; Lou J; Zhou Y; Yuan QA; Weiner LM; Adams GP; Marks JD
Cancer Biother Radiopharm; 2005 Dec; 20(6):603-13. PubMed ID: 16398612
[TBL] [Abstract][Full Text] [Related]
2. An engineering strategy to target activated EGFR with CAR T cells.
Dobersberger M; Sumesgutner D; Zajc CU; Salzer B; Laurent E; Emminger D; Sylvander E; Lehner E; Teufl M; Seigner J; Bobbili MR; Kunert R; Lehner M; Traxlmayr MW
Cell Rep Methods; 2024 Apr; 4(4):100728. PubMed ID: 38492569
[TBL] [Abstract][Full Text] [Related]
3. Magnetic Bead-Immobilized Mammalian Cells Are Effective Targets to Enrich Ligand-Displaying Yeast.
Lown PS; Hackel BJ
ACS Comb Sci; 2020 May; 22(5):274-284. PubMed ID: 32283920
[TBL] [Abstract][Full Text] [Related]
4. Ligand Engineering via Yeast Surface Display and Adherent Cell Panning.
Stern LA; Lown PS; Hackel BJ
Methods Mol Biol; 2020; 2070():303-320. PubMed ID: 31625103
[TBL] [Abstract][Full Text] [Related]
5. Cellular-Based Selections Aid Yeast-Display Discovery of Genuine Cell-Binding Ligands: Targeting Oncology Vascular Biomarker CD276.
Stern LA; Lown PS; Kobe AC; Abou-Elkacem L; Willmann JK; Hackel BJ
ACS Comb Sci; 2019 Mar; 21(3):207-222. PubMed ID: 30620189
[TBL] [Abstract][Full Text] [Related]
6. A semi high-throughput method for screening small bispecific antibodies with high cytotoxicity.
Sugiyama A; Umetsu M; Nakazawa H; Niide T; Onodera T; Hosokawa K; Hattori S; Asano R; Kumagai I
Sci Rep; 2017 Jun; 7(1):2862. PubMed ID: 28588218
[TBL] [Abstract][Full Text] [Related]
7. Optical imaging probes in oncology.
Martelli C; Lo Dico A; Diceglie C; Lucignani G; Ottobrini L
Oncotarget; 2016 Jul; 7(30):48753-48787. PubMed ID: 27145373
[TBL] [Abstract][Full Text] [Related]
8. Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.
Lehmann A; Wixted JH; Shapovalov MV; Roder H; Dunbrack RL; Robinson MK
MAbs; 2015; 7(6):1058-71. PubMed ID: 26337947
[TBL] [Abstract][Full Text] [Related]
9. Combining anti-ERBB3 antibodies specific for domain I and domain III enhances the anti-tumor activity over the individual monoclonal antibodies.
D'Souza JW; Reddy S; Goldsmith LE; Shchaveleva I; Marks JD; Litwin S; Robinson MK
PLoS One; 2014; 9(11):e112376. PubMed ID: 25386657
[TBL] [Abstract][Full Text] [Related]
10. Engineering multivalent antibodies to target heregulin-induced HER3 signaling in breast cancer cells.
Kang JC; Poovassery JS; Bansal P; You S; Manjarres IM; Ober RJ; Ward ES
MAbs; 2014; 6(2):340-53. PubMed ID: 24492289
[TBL] [Abstract][Full Text] [Related]
11. Label-free Growth Receptor-2 Detection and Dissociation Constant Assessment in Diluted Human Serum Using a Longitudinal Extension Mode of a Piezoelectric Microcantilever Sensor.
Capobianco JA; Shih WY; Adams GP; Shih WH
Sens Actuators B Chem; 2011 Dec; 160(1):349-356. PubMed ID: 22888196
[TBL] [Abstract][Full Text] [Related]
12. Impact of intrinsic affinity on functional binding and biological activity of EGFR antibodies.
Zhou Y; Goenaga AL; Harms BD; Zou H; Lou J; Conrad F; Adams GP; Schoeberl B; Nielsen UB; Marks JD
Mol Cancer Ther; 2012 Jul; 11(7):1467-76. PubMed ID: 22564724
[TBL] [Abstract][Full Text] [Related]
13. A rapid method to regenerate piezoelectric microcantilever sensors (PEMS).
Loo L; Wu W; Shih WY; Shih WH; Borghaei H; Pourrezaei K; Adams GP
Sensors (Basel); 2011; 11(5):5520-8. PubMed ID: 22413149
[TBL] [Abstract][Full Text] [Related]
14. Impact of expression system on the function of the C6.5 diabody PET radiotracer.
Miller J; Doss M; McQuillen R; Shaller CC; Tolner B; Yu JQ; Chester K; Robinson MK
Tumour Biol; 2012 Jun; 33(3):617-27. PubMed ID: 22383295
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles.
Peng XH; Wang Y; Huang D; Wang Y; Shin HJ; Chen Z; Spewak MB; Mao H; Wang X; Wang Y; Chen ZG; Nie S; Shin DM
ACS Nano; 2011 Dec; 5(12):9480-93. PubMed ID: 22032622
[TBL] [Abstract][Full Text] [Related]
16. Highly sensitive detection of HER2 extracellular domain in the serum of breast cancer patients by piezoelectric microcantilevers.
Loo L; Capobianco JA; Wu W; Gao X; Shih WY; Shih WH; Pourrezaei K; Robinson MK; Adams GP
Anal Chem; 2011 May; 83(9):3392-7. PubMed ID: 21449604
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the anti-HER2 C6.5 diabody as a PET radiotracer to monitor HER2 status and predict response to trastuzumab treatment.
Reddy S; Shaller CC; Doss M; Shchaveleva I; Marks JD; Yu JQ; Robinson MK
Clin Cancer Res; 2011 Mar; 17(6):1509-20. PubMed ID: 21177408
[TBL] [Abstract][Full Text] [Related]
18. Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging.
Yang L; Mao H; Wang YA; Cao Z; Peng X; Wang X; Duan H; Ni C; Yuan Q; Adams G; Smith MQ; Wood WC; Gao X; Nie S
Small; 2009 Feb; 5(2):235-43. PubMed ID: 19089838
[TBL] [Abstract][Full Text] [Related]
19. Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitro.
Robinson MK; Hodge KM; Horak E; Sundberg AL; Russeva M; Shaller CC; von Mehren M; Shchaveleva I; Simmons HH; Marks JD; Adams GP
Br J Cancer; 2008 Nov; 99(9):1415-25. PubMed ID: 18841159
[TBL] [Abstract][Full Text] [Related]
20. Label-free, all-electrical, in situ human epidermal growth receptor 2 detection.
Capobianco JA; Shih WY; Yuan QA; Adams GP; Shih WH
Rev Sci Instrum; 2008 Jul; 79(7):076101. PubMed ID: 18681738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
